- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
In this Real Money article, John Dorfman explains his feelings toward Emeritus.
Since mid-year, Boston Scientific has risen more than 24%, compared to 3.5% for the Standard & Poor's 500 Index.
In this RealMoney article, John Dorfman shares why telecoms are so unattractive now.
Sometimes, like now, you really might be able to time the market.
Microsoft and Homeowners Choice are among stocks that may protect investors if the market slumps.